Skip to main content
OpenTrials
Completed

NCT Number: NCT03040570

Conservative Versus Liberal Oxygenation Targets in Critically Ill Children

A feasibility study to determine if it is possible to perform a safe, adequately powered, and affordable multi-centre study in critically ill children comparing current practice of liberal targets for systemic oxygen levels with more conservative targets.

Completed

Looking for future studies?

Notify Me

Key information

Age range

39 week–15 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Great Ormond Street Hospital for Children, London, United Kingdom

Loading trial locations.

About this study

Around 19,000 critically ill children are admitted to paediatric intensive care units (PICU) each year in the UK. A large number of these children need breathing support, and this is usually provided through an invasive machine called a 'ventilator'. Clinicians make decisions for treatment based on how much oxygen their patient has in their blood (this is called oxygen saturation or oxygenation) and currently the amount of oxygen critically ill children need is not fully understood. This means that some clinicians use a lower oxygen saturation target, and others, a higher target. This may be problematic as research in neonates (babies) and adults has shown that oxygen saturation levels can influence a patient's chance of survival, how long they stay in hospital and healthcare costs.

Response to oxygen is different in babies, children and adults. This means that the results from the neonatal and adult research are unlikely to be valid or applicable in children due to age-related differences. Urgent high quality clinical evidence is therefore needed to inform on the best targets of oxygenation during critical illness in children.

As large clinical trials are expensive to conduct, it is important to demonstrate that a large-scale trial can be done and that the different components of a trial can all work together. Therefore, the Oxy-PICU study is a 'pilot randomised clinical trial' (a smaller version of the trial we would like to conduct) and will test the feasibility and safety of conducting a large scale trial comparing a restrictive oxygen saturation target (88-92%) with a more liberal oxygen saturation target (>94%). Oxy-PICU will also collect blood and urine samples to allow for in depth study of the biology of the different oxygenation targets.

The pilot trial will take place at three PICUs (two in London and one in Southampton) and aims to include between 115-125 eligible children over six months. Given the emergency nature of these children and the need to provide immediate care, informed consent will be sought after the children are entered into the study (this is known as deferred consent).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • less than 16 years and > 38 weeks corrected gestational age
  • receiving supplemental oxygen for abnormal gas exchange
  • emergency admission accepted to a participating paediatric intensive care unit (PICU) requiring mechanical ventilation within first 6 hours of face-to-face contact with PICU staff or transport team

Exclusion criteria

  • recruited to Oxy-PICU in a previous admission
  • brain pathology/injury as a primary reason for admission (e.g traumatic brain injury, post-cardiac arrest, stroke, convulsive status epilepticus without aspiration)
  • known pulmonary hypertension
  • known or suspected sickle cell disease
  • known or suspected uncorrected congenital cardiac disease
  • End-of-life care plan in place with limitation of resuscitation
  • not expected to survive PICU admission
  • receiving long-term mechanical ventilation prior to this admission (non-invasive ventilation or invasive ventilation)

Treatment and study plan

Conservative oxygenation target

Procedure

Participants allocated to the conservative oxygenation target group will receive supplemental oxygen and ventilator settings at the discretion of the treating clinical team with the aim of peripheral oxygen saturations remaining 88-92% (inclusive).

Liberal oxygenation target

Procedure

Participants allocated to the liberal oxygenation target group will receive supplemental oxygen and ventilator settings at the discretion of the treating clinical team with the aim of peripheral oxygen saturations remaining >94%.

Primary outcomes

  1. Number of eligible patients recruited per site per month

    Time frame: Baseline

Secondary outcomes

  1. Proportion of parents/legal representatives refusing deferred consent

    Time frame: Through study completion, an average of 24 hours

  2. Proportion of eligible patients randomised

    Time frame: Baseline

  3. Distribution of time to randomisation

    Time frame: Baseline

  4. Proportion of systemic oxygen saturations within the target range in each group

    Time frame: Through study completion, an average of 72 hours

  5. Proportion of patients in each arm requiring other treatments influencing tissue oxygen delivery (blood transfusion, inotropic support)

    Time frame: Through study completion, an average of 72 hours

  6. Length of ventilation - proportion of randomised patients with outcome available in each group

    Time frame: Through study completion, an average of 2 days

  7. Length of ventilation - mean (standard deviation) in each group

    Time frame: Through study completion, an average of 2 days

  8. Length of ventilation - median and quartiles in each group.

    Time frame: Through study completion, an average of 2 days

  9. Observed adverse events

    Time frame: 28 days

  10. Time taken for data collection and entry

    Time frame: 28 days

  11. Measurement of ischemia-modified albumin (plasma)

    Time frame: 72 hours

  12. Measurement of malondialdehyde (plasma)

    Time frame: 72 hours

  13. Measurement of total antioxidant status (plasma)

    Time frame: 72 hours

  14. Length of PICU stay - proportion of randomised patients with outcome available in each group

    Time frame: Through study completion, an average of 2 days

  15. Length of PICU stay - mean (standard deviation) in each group.

    Time frame: Through study completion, an average of 2 days

  16. Length of PICU stay - median and quartiles in each group.

    Time frame: Through study completion, an average of 2 days

  17. Hospital mortality - proportion of randomised patients with outcome available in each group

    Time frame: Through study completion, an average of 2 days

  18. Hospital mortality - number (percentage) in each group.

    Time frame: Through study completion, an average of 2 days

  19. PICU mortality - proportion of randomised patients with outcome available in each group

    Time frame: Through study completion, an average of 2 days

  20. PICU mortality - number (percentage) in each group.

    Time frame: Through study completion, an average of 2 days

  21. Days of organ specific support - proportion of randomised patients with outcome available in each group

    Time frame: Through study completion, an average of 2 days

  22. Days of organ specific support - mean (standard deviation) in each group

    Time frame: Through study completion, an average of 2 days

  23. Days of organ specific support - median and quartiles in each group

    Time frame: Through study completion, an average of 2 days

  24. Measurement of hypoxia-inducible factor-1 alpha mRNA expression (leukocytes)

    Time frame: 72 hours

Sponsors and collaborators

Lead sponsor

Great Ormond Street Hospital for Children NHS Foundation Trust

Other

Collaborators

  • Intensive Care National Audit & Research Centre
  • St Mary's Hospital, London
  • University College, London
  • University Hospital Southampton NHS Foundation Trust
  • University of Southampton

Registry information

Official study title

A Randomised Pilot Multiple Centre Trial of Conservative Versus Liberal Oxygenation Targets in Critically Ill Children

Acronym: Oxy-PICU

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Feb 2, 2017
Registry last updated
Feb 23, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.